Health

India’s Covaxin Found To Offer 77.8 Percent Protection Against COVID-19: Study

GENEVA, Nov 12 — Data from Phase 3 trials of the coronavirus vaccine Covaxin, developed in India, has shown that two doses offer 77.8 per cent protection against COVID-19, according to findings published Thursday in The Lancet medical journal.

Covaxin, known by the code BBV152, is an inactivated virus-based COVID-19 vaccine developed by Bharat Biotech in collaboration with the Indian Council of Medical Research and National Institute of Virology.

The drug on Nov 3 was granted emergency use approval by the World Health Organisation (WHO) for adults 18 years and older and is the eighth jab to be given the green light by the health body.

The WHO determined that Covaxin met its standards for protection against COVID-19 and “that the benefit of the vaccine far outweighs risks.”

It recommended the vaccine be administered in two doses, with an interval of four weeks in age groups 18 and above, reported Anadolu Agency.

The jab has not been advised for pregnant women as available data is “insufficient” to “assess vaccine safety or efficacy in pregnancy.”

Other COVID-19 vaccines approved by the specialised UN agency are Pfizer-BioNTech, Oxford-AstraZeneca, Johnson & Johnson’s Janssen, Moderna, Sinopharm, and Sinovac.

The Phase 3 trials ran from Nov 16, 2020 until May 17, 2021, and included participants between 18 and 97 years old, said the article in the scientific journal.

Trial participants were given two doses of either Covaxin or a placebo.

Participants considered at high risk for COVID-19 infection were prioritised, with 2,750 participants above 60 years of age and 5,724 participants with at least one preexisting condition included in the study.

Participants were recruited from 25 hospitals across India for geographic diversity.

Covaxin “was well-tolerated by all trial participants; 12 per cent of both groups reported an adverse event, with no significant difference in the number of events between the placebo and BBV152 groups,” said the findings.

Sources: BERNAMA

Adib Mohd

Recent Posts

When Creativity Meets Comfort: LEGO® and IKEA Malaysia Reimagine Home Decor

When Creativity Meets Comfort: LEGO® and IKEA Malaysia Reimagine Home Decor With its latest collection… Read More

22 hours ago

TCL Malaysia Opens First-Ever Brand Store at Sunway Pyramid by Vivid Concepts

TCL, a global leading consumer electronics brand, officially launched its first-ever TCL Brand Store in… Read More

22 hours ago

New AwAS Speed Cameras Are Everywhere in Malaysia, Here’s the Full List

Heads up, Malaysian drivers! If you’ve been putting the pedal to the metal on highways… Read More

1 day ago

Zizan Razak Is Now G-SHOCK Malaysia’s First-Ever Brand Ambassador And It Just Makes Sense

From comedy king to watch icon, Zizan Razak has just landed a major new role… Read More

5 days ago

Honouring the Everyday Athlete: ASICS Shares Stories at the Ladies Pickleball Special

On 24 May, ASICS Malaysia’s Ladies Pickleball Special 2025 saw a celebration of strength, laughter… Read More

5 days ago

Pavilion Bukit Jalil Hosts “All Play All Day” to Mark Mattel’s 80th Anniversary

This school holiday, Pavilion Bukit Jalil is turning up the fun with Mattel’s 80th anniversary… Read More

5 days ago

This website uses cookies.